# Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection

> **NCT04408209** · NA · COMPLETED · sponsor: **National and Kapodistrian University of Athens** · enrollment: 60 (actual)

## Conditions studied

- COVID-19 Infection

## Interventions

- **PROCEDURE:** Convalescent Plasma

## Key facts

- **NCT ID:** NCT04408209
- **Lead sponsor:** National and Kapodistrian University of Athens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-23
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-12-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04408209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04408209, "Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04408209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*